5,786 trials (keyword fallback)
Cheek Augmentation · Correction of Age-related Midface Contour Deficiencies
Primary: Non-inferiority of RHA®4 to the Change From Baseline for Subjects Treated With Comparator Product at 8 Weeks After the Last Treatment as Assessed by the BLE Using the…
Rhinitis, Allergic, Perennial and Seasonal
Primary: Number of Participants With Overall Preference for Nasal Spray Assessed by Preference Questionnaire. — 96; 59; 30; 57 Participants — p=<0.001
Recurrent Herpes Labialis
Primary: Clinician Assessed Duration of Complete Healing of the Herpetic Episode — 129.6; 154.6 hours
Recurrent Herpes Labialis
Primary: Clinician Assessed Duration of the Classical Herpetic Lesion — 162.7; 163.6 hours
Diabetes Mellitus, Type 2
Primary: Change in Glycated Haemoglobin (HbA1c) (%) From Baseline to the End of 26 Weeks - DINAMOᵀᴹ — NA; 0.33; -0.17; -0.49 Percent change — p=0.2935
Perioral Rhytids · Aging · Wrinkle
Primary: Change From Baseline in Perioral Rhytids Severity Rating Scale (PR-SRS) Score Rated by the Blinded Live Evaluator (BLE) at Week 8 After Last Treatment. — 121; 4; 29; 47…
Lip Augmentation · Lip
Primary: Change in TLFS Score (Teoxane Lip Fullness Scale) Between Baseline and Week 12 After Last Treatment of RHA®3 Versus Control Device, as Assessed by the BLE — 1.0; 0.8…
Alcohol Concentration Values · Alcohol Intoxication
Primary: Percent Alcohol Concentration Measured by Breathalyzer — 0.099; 0.086; 0.099; 0.099 percent Breathalyzed alcohol content — p=<0.0001
Adjustment Disorder With Anxious Mood
Primary: Hamilton Anxiety Scale (HAM-A) Score — -12.5; -12.6 score on a scale — p=0.9338
Heart Failure · Arrhythmias, Cardiac · Sudden Cardiac Death
Primary: Number of Participants With Ventricular Arrhythmia Associated Symptoms - ICD/CRT-D Cohorts — 3; 8 Participants
Glabellar Lines · Wrinkles
Primary: Proportion of Composite Responders Who Achieve at Least a 1-point Reduction From Baseline in Glabellar Line Severity Score (GLSS) at Maximum Frown. — 27; 26 Participants
Elevated Intraocular Pressure (IOP)
Primary: Mean Percent Intraocular Pressure (IOP) Change — -14.6 mean % Intraocular Pressure (IOP) change
Delirium · Respiratory Depression · Overmedication
Primary: Success of Blinding — 1; 1 Participants
Diabetes Mellitus, Type 2
Primary: CD34+ Endothelial Progenitor Cell Number (EPC) Per Mononuclear Cells (MNC) Ratio — 0.10; 0.23; 0.12; 0.13 ratio
Parkinson's Disease
Primary: Number of Participants With Adverse Events — 2; 2; 2; 1 participants